#bristolmyerssquibb — Public Fediverse posts

BIOTECH · Bristol Myers' lung drug works at low dose, fails at high

A key lung-scarring drug succeeded at 60mg but missed at 120mg, while a second trial slowed a rare tumor's growth.

Read the rest at: https://thedailyfathom.com/biotech/2026-10-13/

#Biotech #BristolMyersSquibb #admilparant #RayzeBio #TheDailyFathom

AZN spikes 6% after report it denies AstraZeneca-BMS merger talks

Investing.com – AstraZeneca shares surged approximately 6% on Wednesday after a senior source told Reuters there are “no…
#EuropeSays #Britain #Europe #EU #AstraZeneca #bristolmyerssquibb #combination #discussions #mergerspeculation
https://www.europesays.com/britain/141387/

https://www.europesays.com/britain/141387/ AZN spikes 6% after report it denies AstraZeneca-BMS merger talks #AstraZeneca #BristolMyersSquibb #combination #discussions #MergerSpeculation

South Korea’s KOSDAQ Pharma Index Plunges 10% in a Month, Down 36% Year-to-Date — BigGo Finance

The pharmaceutical sector posted the weakest performance on South Korea’s KOSDAQ market over the past month. A combination…
#EuropeSays #Korea #KR #SouthKorea #ABLBio #BankofKorea #BristolMyersSquibb #HanaSecurities #KOSDAQ #OrumTherapeutics #pharmaceuticalsectorindex #YonhapInfomax
https://www.europesays.com/korea/177269/

https://www.europesays.com/ch/139818/ Novartis pays $575 million upfront for Abogen’s mRNA autoimmune therapy in deal worth up to $7.8 billion — BigGo Finance #ABO2203 #AbogenBiosciences #Akeso #AstraZeneca #BristolMyersSquibb #ChimagenBiosciences #GSK #HengruiPharmaceuticals #HRS1596 #Ivonescimab #Novartis #NovoNordisk #RapcabtageneAutoleucel #SummitTherapeutics

https://www.europesays.com/uk/1230117/ Bristol Myers trial revisions shake confidence in new class of fibrosis drugs #Bristol #BristolMyersSquibb #Britain #DrugClass #DrugTherapy #England #GreatBritain #IdiopathicPulmonaryFibrosis #LiverDamage #LiverInjury #PulmonaryFibrosis #spokesperson #UK #UnitedKingdom

https://www.europesays.com/uk/1228270/ Bristol Myers Squibb (BMY) Reported 41.1% MRD Negative Responses In Phase 3 Trial #Bristol #BristolMyersSquibb #Britain #CompleteResponse #CompleteResponseRates #England #EXCALIBERRRMM #GreatBritain #MultipleMyeloma #MyelomaTreatment #UK #UnitedKingdom #ZENBEXUS

https://www.europesays.com/uk/1227714/ 3 Numbers That Explain Bristol Myers Squibb’s Dirt Cheap Valuation #Bristol #BristolMyersSquibb #Britain #DrugProducts #England #GreatBritain #PatentExpirations #UK #UnitedKingdom

https://www.europesays.com/dk/176509/ Novo Nordisk Says Higher Semaglutide Dose Cuts Heart Risks More Than Switching to Lilly’s Tirzepatide — BigGo Finance #BristolMyersSquibb #EliLilly #GIP #GLP1 #HengruiPharma #HRS1596 #Nanexa #NovoNordisk #semaglutide #Tirzepatide

https://www.europesays.com/dk/175117/ Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026? #BristolMyersSquibb #FreeCashFlow #GrowthPortfolio #NovoNordisk

https://www.europesays.com/ch/135691/ Novartis, BMS halt autoimmune CAR-T trials over adverse events #AdverseEvents #AutoimmuneDisease #biotech #BristolMyersSquibb #CART #Cell&GeneTherapy #FierceBiotechHomepage #Novartis

AstraZeneca shares oversold after trial flops and merger talk, says UBS

AstraZeneca shares oversold after trial flops and merger talk, says UBS Proactive uses images sourced from Shutterstock UBS…
#EuropeSays #Britain #Europe #EU #AstraZeneca #bristolmyerssquibb #mega-merger #UBSProactive
https://www.europesays.com/britain/130039/

https://www.europesays.com/britain/130039/ AstraZeneca shares oversold after trial flops and merger talk, says UBS #AstraZeneca #BristolMyersSquibb #MegaMerger #UBSProactive

https://www.europesays.com/se/390136/ Läkemedelsbolag pressar USA om Kina-affärer #Abbvie #AstraZeneca #BristolMyersSquibb #Business #Economy #Ekonomi #EliLilly #MerckKGaA #Pfizer #SE #Svenska #Sverige #Sweden #Swedish

AstraZeneca (LSE:AZN) Merger Talk Fades, Is The Stock Undervalued?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
#EuropeSays #Britain #Europe #EU #AstraZeneca #bristolmyerssquibb #shareprice
https://www.europesays.com/britain/129151/

https://www.europesays.com/britain/129151/ AstraZeneca (LSE:AZN) Merger Talk Fades, Is The Stock Undervalued? #AstraZeneca #BristolMyersSquibb #SharePrice

https://www.europesays.com/ch/134277/ AstraZeneca shares oversold after trial flops and merger talk, says UBS #AstraZeneca #BristolMyersSquibb #MegaMerger #UBS #UBSProactive

https://www.europesays.com/ch/131636/ AstraZeneca shares oversold after trial flops and merger talk, says UBS #AstraZeneca #BristolMyersSquibb #MegaMerger #UBS #UBSProactive

AstraZeneca shares oversold after trial flops and merger talk, says UBS

AstraZeneca shares oversold after trial flops and merger talk, says UBS Proactive uses images sourced from Shutterstock UBS…
#EuropeSays #Britain #Europe #EU #AstraZeneca #bristolmyerssquibb #mega-merger #UBSProactive
https://www.europesays.com/britain/125416/

https://www.europesays.com/britain/125416/ AstraZeneca shares oversold after trial flops and merger talk, says UBS #AstraZeneca #BristolMyersSquibb #MegaMerger #UBSProactive

https://www.europesays.com/ch/131506/ The Medicine Maker | Novartis and BMS Pause Autoimmune CAR T Trials Over Safety Concerns #AutoimmuneDiseases #BristolMyersSquibb #CARTTherapy #ClinicalTrials #ImmuneEffectorCellAssociatedHemophagocyticSyndrome #Novartis #RapcabtageneAutoleucel #SafetyConcerns #ZolacabtageneAutoleucel

GSK Pays Up to $750 Million for Chimagen’s Next-Generation Blood Cancer Therapy — BigGo Finance

GSK is doubling down on its return to oncology, agreeing to pay as much as $750 million for…
#EuropeSays #Britain #Europe #EU #GSK #Berenberg #bristolmyerssquibb #ChimagenBiosciences #CMG1A46 #dolutegravir #Gilead #HeshamAbdullah #Johnsonu0026Johnson #LukeMiels #Novartis #Talvey #Tecvayli #ZhenhaoZhou
https://www.europesays.com/britain/124754/

https://www.europesays.com/britain/124754/ GSK Pays Up to $750 Million for Chimagen’s Next-Generation Blood Cancer Therapy — BigGo Finance #Berenberg #BristolMyersSquibb #ChimagenBiosciences #CMG1A46 #dolutegravir #Gilead #GSK #HeshamAbdullah #JohnsonU0026Johnson #LukeMiels #Novartis #Talvey #Tecvayli #ZhenhaoZhou

https://www.europesays.com/es/757086/ Sanidad financia la primera doble inmunoterapia de BMS para cáncer colorrectal metastásico #BristolMyersSquibb(BMS) #cáncer #ES #España #Health #IndustriaFarmacéutica #MinisterioDeSanidad #Salud #Spain

SK Biopharmaceuticals Recruits Novartis Veteran Kim Tae-ho to Lead New Neuroscience R&D Division — BigGo Finance

SK Biopharmaceuticals (326030) is strengthening its full-cycle R&D capabilities—spanning candidate discovery, clinical development, and commercialization—through a series of…
#EuropeSays #Korea #KR #SK #AbbVie #BristolMyersSquibb #KimSoo-young #KimTae-ho #LeeDong-hoon #Novartis #RyanKruger #SKBiopharmaceuticals #SKGroup #SKLifeScienceLabs #SunitaMisra #Xcopri
https://www.europesays.com/korea/146781/

https://www.europesays.com/ch/127341/ SK Biopharmaceuticals Recruits Novartis Veteran Kim Tae-ho to Lead New Neuroscience R&D Division — BigGo Finance #AbbVie #BristolMyersSquibb #KimSooYoung #KimTaeHo #LeeDongHoon #Novartis #RyanKruger #SKBiopharmaceuticals #SKLifeScienceLabs #SunitaMisra #Xcopri

https://www.europesays.com/ch/125100/ Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts #BioPharmaDive #Bristol #BristolMyers #BristolMyersSquibb #KyvernaTherapeutics #Novartis #Song

https://www.europesays.com/ch/124783/ Panmure Liberum says OxfordBiomedica share fall overdone after Novartis and BMS pause trials #BristolMyersSquibb #Novartis #OXB #OxfordBiomedica #PanmureLiberum

https://www.europesays.com/ch/124286/ Novartis Halts Eight CAR-T Trials After Three Patient Deaths — BigGo Finance #BristolMyersSquibb #CARTCellTherapy #lupus #MultipleSclerosis #Novartis #NovartisAG #RapCel #ZolaCel

https://www.europesays.com/ch/124124/ Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns #BioPharmaDive #BristolMyers #BristolMyersSquibb #Novartis #ZolaCel

https://www.europesays.com/at/368435/ Umfassende Überprüfung – Mehrere Todesfälle: Novartis stoppt nun Studien – Kronen Zeitung #AT #Austria #BristolMyersSquibb #Business #Companies #Companies&Markets #Markets #Märkte #Österreich #Schweizer #Unternehmen #Unternehmen&Märkte

AstraZeneca shares slump after $400bn BMS merger rumours

Shares in AstraZeneca dropped by nearly 3% at market open after a report that the drugmaker is in…
#EuropeSays #Britain #Europe #EU #AstraZeneca #bristolmyerssquibb #marketcapitalisation #mega-merger #ordinaryshares #pharmaceuticalcompanies #PharmaceuticalTechnology
https://www.europesays.com/britain/112405/

https://www.europesays.com/britain/112405/ AstraZeneca shares slump after $400bn BMS merger rumours #AstraZeneca #BristolMyersSquibb #MarketCapitalisation #MegaMerger #OrdinaryShares #PharmaceuticalCompanies #PharmaceuticalTechnology

https://www.europesays.com/uk/1171113/ Cellares rebukes Bristol Myers’ criticism of its cell therapy technology #Breyanzi #Bristol #BristolMyersSquibb #Britain #CabalettaBio #CARTTherapy #CellShuttle #CellTherapyManufacturing #Cellares #England #FabianGerlinghaus #GreatBritain #layoffs #manufacturing #pharma #SouthSanFrancisco #UK #UnitedKingdom

https://www.europesays.com/3216906/ Cellares rebukes Bristol Myers’ criticism of its cell therapy technology #america #Breyanzi #BristolMyersSquibb #CabalettaBio #CARTTherapy #CellShuttle #CellTherapyManufacturing #Cellares #FabianGerlinghaus #layoffs #manufacturing #pharma #science #SouthSanFrancisco #technology #UnitedStates #UnitedStatesOfAmerica #US #USA

https://www.europesays.com/uk/1162934/ Bristol Myers’ partner Biokin says bispecific ADC clears fourth cancer trial in China #Biokin #BispecificAntibody #Bristol #BristolMyersSquibb #Britain #China #England #GreatBritain #IzalontamabBrengitecan #LungCancer #R&D #UK #UnitedKingdom

https://www.europesays.com/uk/1162517/ What Could Bristol Myers Squibb (BMY) AI Antibody Deal Mean For Drug Discovery? #Bristol #BristolMyersSquibb #Britain #ChaiDiscovery #DrugDiscovery #England #GreatBritain #UK #UnitedKingdom

https://www.europesays.com/dk/148230/ 3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now #AttractiveOption #BristolMyersSquibb #CVSHealth #DividendStocks #HealthcareSector #NovoNordisk

Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk — or a Disaster Waiting to Happen?

In recent weeks, two pharmaceutical stocks, AstraZeneca (NYSE: AZN) and Bristol Myers Squibb (NYSE: BMY), have become the…
#EuropeSays #Britain #Europe #EU #AstraZeneca #bristolmyerssquibb #mergerrumors #pharmaceuticalstocks
https://www.europesays.com/britain/103186/

https://www.europesays.com/britain/103186/ Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk — or a Disaster Waiting to Happen? #AstraZeneca #BristolMyersSquibb #MergerRumors #PharmaceuticalStocks

AstraZeneca y Bristol Myers Squibb en conversaciones para una mega-fusión de 400 mil millones de dólares.

AstraZeneca, el gigante farmacéutico británico, y Bristol Myers Squibb (BMS), una empresa estadounidense líder, están en conversaciones para una posible mega-fusión valorada en 400.000 millones de dólares. Este movimiento estratégico, si tiene éxito, cr…

#Akerix #IA #AstraZeneca #BristolMyersSquibb #ReinoUnido
https://akerix.com/es/article/pharmaceutical-mega-merger
📷 Süddeutsche Zeitung

BIOTECH · AstraZeneca, Bristol Myers explored $400B merger

The two drugmakers held preliminary talks about a deal that would create one of the world's largest pharma firms.

Read the rest at: https://thedailyfathom.com/biotech/2026-08-03/

#Biotech #AstraZeneca #BristolMyersSquibb #TheDailyFathom

#Pharma: #AstraZeneca erwägt Mega-Fusion mit #US Rivalen #BristolMyersSquibb
Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb https://share.google/hevExeNmlIQtYIEyd

AstraZeneca för samtal med Bristol Myers Squibb om samgående i en jätteaffär värd 400 miljarder dollar https://borsposten.se/astrazeneca-for-samtal-med-bristol-myers-squibb-omsamgaende-i-en-jatteaffar-vard-400-miljarder-dollar/ #aktier #AstraZeneca #BristolMyersSquibb

🚀 Bristol Myers Squibb teams up with Accenture to launch an AI‑powered content hub in Mumbai. The $130 M Mosaic platform will blend clinical data, cloud automation & data‑driven marketing to speed up insights. Curious how pharma & tech are reshaping innovation? Read on! #AI #BristolMyersSquibb #Accenture #Mosaic

🔗 https://aidailypost.com/news/bristol-myers-squibb-accenture-launch-ai-content-hub-mumbai

Trump empuja a las farmacéuticas a subir los precios de los medicamentos en Europa para bajarlos en EE UU

https://web.brid.gy/r/https://elpais.com/sociedad/2025-10-06/trump-empuja-a-las-farmaceuticas-a-subir-los-precios-de-los-medicamentos-en-europa-para-bajarlos-en-ee-uu.html

https://www.fogolf.com/1022613/pfizer-ceo-attending-25-million-fundraiser-at-trumps-golf-club-sources-say/ Pfizer CEO attending $25 million fundraiser at Trump’s golf club, sources say #AlbertBourla #BristolMyersSquibb #Donald #DonaldTrump #DonaldTrumpGolf #DonaldTrumpGolfing #DrugPrices #Pfizer #PharmaceuticalCompanies #PresidentTrump #trump #TrumpGolf #TrumpGolfing #WhiteHouse

Gilead’s Trodelvy stumbles in late-stage trials but remains prized cancer asset—BMS axes Eisai ADC pact 3 years after paying $650M for would-be Elahere rival —Supreme Court’s Chevron Doctrine ruling could limit FDA’s regulatory authority—http://bit.ly/w28kSd #gileadsciences #cancer #antibodydrugconjufate #eisai #bristolmyerssquibb #supremecourt #fda #chevrondoctrine #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

5 FDA decisions to watch in the second half of 2024—Lilly sees path for Zepbound’s label expansion with phase III sleep apnea win —BMS gets FDA approval for Krazati in colorectal cancer—http://bit.ly/w28kSd #fda #elililly #sleepapnea #bristolmyerssquibb #colorectalcancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

ASCO: With Opdivo-Yervoy combo, Bristol Myers calls Roche and AstraZeneca's bets in first-line liver cancer—FDA panel to review psychedelic drug MDMA for first time — Abbott’s OTC glucose monitor ‘will grow the market’—http://bit.ly/w28kSd #asco2024 #oncology #cancer #bristolmyerssquibb #livercancer #mdma #fda #abbottlabs #cgm #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

J&J to buy Proteologix and its dual-targeting antibody drugs for $850M—Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data —FDA approves expanded use of Bristol Myers' cancer cell therapy --http://bit.ly/w28kSd #jnj #biogen #als #celltherapy #fda #bristolmyerssquibb #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Repertoire pivot pays dividends with Bristol Myers deal—AstraZeneca and Daiichi Sankyo’s Enhertu shows promise in breast cancer trial —Ono swoops on Deciphera in $2.4 billion takeover--http://bit.ly/w28kSd #bristolmyerssquibb #astrazeneca #daiichisankyo #breastcancer #clinicaltrials #mergersandacquisitions #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

BMS to cut 2,200 jobs in $1.5B restructuring as Opdivo sales drop in Q1—AstraZeneca leaps after smashing first-quarter forecasts —CureVac initiates H5N1 avian influenza vaccine study--http://bit.ly/w28kSd #bristolmyerssquibb #restructuring #layoffs #earnings #astrazeneca #h5n1 #vaccines #birdflu #curevac #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

J&J scoops up cardio medtech Shockwave Medical for $13.1B—FDA allows expanded use of Bristol Myers' cell therapy for blood cancer—Boehringer to lay off salespeople as Humira biosimilar sales lag--http://bit.ly/w28kSd #jnj #shockwavemedical #fda #mergersandacquisitions #celltherapy #bloodcancer #bristolmyerssquibb #humira #boehringer #layoffs #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

BMS racks up phase III win in liver cancer targeted by AstraZeneca and Roche—J&J alleges ex-staffer downloaded thousands of files in move to Pfizer—Orchard sets new gene therapy price tag at $4.25M—the steepest of any drug in the US--http://bit.ly/w28kSd #bristolmyerssquibb #livercancer #roche #astrazeneca #jnj #pfizer #tradesecrets #genetherapy #drugpricing #orchardtherapeutics #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Madrigal’s Rezdiffra energizes MASH Space, sets bar for future therapies—BMS, AstraZeneca, Novartis add to 2024 M&A upswing—AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers--http://bit.ly/w28kSd #mash #nash #liverdisease #novartis #bristolmyerssquibb #novartis #mergersandacquisitions #drugpricing #inhalers #astrazeneca #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Lilly makes weight-loss drug Zepbound available through Amazon pharmacy—Merck to start trials investigating single dosing regiments of HPV vaccine—FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies--http://bit.ly/w28kSd #amazon #elililly #zebound #merck #clinicaltrials #hpv #vaccines #gardasil #jnj #bristolmyerssquibb #cart #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

ADC market will remain hot in oncology, reaching $30B by 2028—Bristol Myers Squibb reports data from Phase III multiple sclerosis trial—RSV vaccines may be linked to small increased risk of developing Guillain-Barré syndrome, data suggest--http://bit.ly/w28kSd #antibodydrugconjugates #oncology #clinicaltrials #mutliplesclerosis #rsv #vaccines #bristolmyerssquibb #guillainbarre #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Federal #court in #Texas dismissed #lawsuit brought by heavy-hitting #pharmaceutical trade group, #PhRMA, which argued forcing #drug makers to negotiate #Medicare #drugprices is #unconstitutional. The big pharmaceutical companies suing government directly over negotiations include J&J, #BristolMyersSquibb, #NovoNordisk, #Merck, and #AstraZeneca. District Judge David Ezra found they first need to bring claims through an administrative review process under the #MedicareAct https://arstechnica.com/science/2024/02/judge-tosses-big-pharma-suit-claiming-drug-price-negotiation-is-unconstitutional/

Viking Therapeutics' weight-loss drug trial success spurs share surge—BioMarin hit with DOJ subpoena on sponsored testing for rare diseases—Bristol Myers CEO says India to have largest R&D presence outside US by 2025--http://bit.ly/w28kSd #weightloss #clinicaltrials #biomarin #doj #raredisease #india #bristolmyerssquibb #researchanddevelopment #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma